Switzerland· 24041003

Nozinan 100 mg, Filmtabletten

A levomepromazine product containing levomepromazinum, registered in Switzerland by Neuraxpharm Switzerland AG and dispensed under Swissmedic category B. The same ATC class is registered in 16 of our 19 countries.

Cat B (Swissmedic)ATC N05AA02

Checked against Swissmedic (Switzerland) on September 12, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about levomepromazinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Levomepromazine is registered in 16 of 19 countries.

Countries holding a registration under ATC N05AA02 (levomepromazine), each read from that country’s own register.

This record: Switzerland, from Swissmedic (Switzerland)
8 of them publish a price we can compare per daily dose

Search levomepromazine products by name

Levomepromazine · ATC N05AA02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of levomepromazine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.30 in Italy to $6.20 in Switzerland — a ×4.8 gap.

Switzerland: $6.20 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Levomepromazine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$6.20
IT Italy$1.30

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)

Active substance: levomepromazinum
Manufacturer: Neuraxpharm Switzerland AG
Country: Switzerland (CH)
ATC code: N05AA02
ATC class: Levomepromazine
Defined daily dose: 0.3 g, O
Swissmedic category: B
Reimbursed: No
Source register: Swissmedic (Switzerland)
Last checked: September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

349 interactions on record for levomepromazine.

Graded by severity as the source publishes them — 44 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check levomepromazine against other medicines How interaction checks work

Levomepromazine · interactions on record

349 records

44 severe
263 moderate
8 minor

Most severe, free to view

MetoclopramideA03FA01severe
DolasetronA04AA04severe
Potassium chlorideA12BA01severe
Potassium citrateA12BA02severe

34 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levomepromazine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levomepromazine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Nozinan
Belgium · Nozinan
Czechia · Tisercin
Germany · Levomepromazin Aspire, Levomepromazin Neuraxpharm
Denmark · Levomepromazine Aspire
Estonia · Levomepromazine Orion
Spain · Sinogan
Finland · Levomepromazine Aspire, Levomepromazine Orion
France · Nozinan
United Kingdom (Northern Ireland) · Levomepromazine Hydrochloride Wockhardt Uk, Levomepromazine Maleate Morningside Healthcare
Greece · Nozinan
Croatia · Nozinan
Hungary · Tisercin
Ireland · Nozinan
Italy · Nozinan
Lithuania · Tisercin
Luxembourg · Nozinan
Latvia · Tisercin
Netherlands · Nozinan
Norway · Levomepromazine Aspire, Levomepromazine Orion
Poland · Levomentis, Tisercin
Portugal · Nozinan
Romania · Levomepromazin Aspire, Levomepromazin Terapia
Sweden · Levomepromazine Aspire, Levomepromazine Orion
Slovakia · Tisercin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/8b4233aa-d35f-49ce-b272-b849489f8a3d
GET /v1/drugs/8b4233aa-d35f-49ce-b272-b849489f8a3d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}

API reference MCP server Plans

See everything about levomepromazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console